How employees with careers in nursing are critical at Merck
Nurses' clinical expertise and patient experience provide valuable insight across our company
April 10, 2024
Share this article
Nurses do vital work every day. The care they provide makes a profound difference in the lives of patients and their families. And that’s why employees with careers in nursing are critical at Merck.
Esther Smith-Howell, associate director, outcomes research, said her nursing background provides her with valuable experience she applies as a business scientist.
“I understand patients’ concerns and questions related to medications and care, their need for education and information, the social context that may affect their ability to access and pay for medications and care,” said Smith-Howell. “It helps me think holistically about research and patients.”
"Integrating the patient perspective into solving scientific research problems is critical for successful patient outcomes."
— Esther Smith-Howell, Ph.D., MSHP, R.N.
Associate director, outcomes research, health care delivery research
A sincere desire to help patients
From product safety and labeling to marketing, clinical operations and medical affairs, we employ hundreds of registered nurses in non-clinical positions.
“Nurses are a valuable resource to our company in terms of their real-world patient experience, clinical expertise and talent,” said Mary Elmer, executive director, patient innovation & engagement, and a nurse herself. “They bring important perspectives to help inform our business.”
That’s why Elmer, with now retired fellow nurse Jan Nissen, created the Merck Nurses Network, a voluntary group of nurses who work across functions and roles throughout the company. Their mission is to harness the collective knowledge of nurses to provide meaningful insight across the business, even beyond their day jobs.
“The network is a great way for peers to connect and share experiences and learnings, always with a focus on patients,” said Elmer.
"Nurses share a special bond. There's true camaraderie between us fueled
by a sincere desire to help patients."
One of those members is Steve Morin, whose varied nursing experiences working directly with patients help inform his current role as director of regulatory policy. He’s served as a bone marrow transplant nurse in a hospital, research nurse in clinical trials, and nurse officer in the U.S. public health service, where he worked with a number of underserved populations from around the world.
“These experiences allowed me to see health from a global perspective, and I use that background now as I advocate for regulatory policies that will help improve patient outcomes.”
Steve Morin, MSHE, BSN Director, regulatory policy
Nurses at Merck are critical to our work
The nurses’ diverse backgrounds and skillsets — surgical, oncology, primary care, pediatrics, among others — also allow for valuable insight overall and targeted support when needed in a specific area of focus.
Here are four ways employees use their nursing expertise to make clinical and non-clinical impact:
Drug delivery development
Providing input on early design models for our product teams to create user-friendly devices as well as easy-to-understand accompanying patient education materials.
Package design
Supporting human factor testing, which focuses on the interactions between people and the product, by providing perspective on the end-user experience of patients and the health care professionals who give our products to patients.
Communications materials
Providing personal and professional perspectives, including how patients and their families digest health information, cultural sensitivities, and other insights, so we deliver health literate information that is clear for people who use our products.
Clinical support
Mobilizing teams of nurses to assist our employee health department, including stepping away from their non-clinical day jobs to provide critical support and help prevent disruption in business activities.
Our colleagues share their thoughts on being nurses at Merck:
“With Merck’s patient-centric values, I’m empowered with valuable tools to help patients. Merck has always been committed to science and education . . . it’s a perfect organization for a nurse to thrive in.”
“My background as a nurse gives me a unique perspective. I get it. I’ve been there when I’ve had to deliver bad news. I’ve also been there when I have great news to deliver. I’ve watched patients’ daily struggles. They’ve shared their stories with me. In my daily work, I’m constantly thinking about ‘how do we make things better for patients.’”
— Dr. Lisa Lea, DNP, FNP-C
Director, patient innovation and engagement
Cynthia Thompson
“With a history of cancer in my family, I became a nurse to try to understand why so many Black Americans die from this disease. I now get to teach physicians about our medications and hope to help make a difference in the lives of people living with cancer.”
— Cynthia Thompson, R.N., M.S.N.
Oncology sales representative, women’s health
“Merck is a great place for nurses to work, and we need more of them. As the role most closely connected to the patient, we’re also the voice that can function as advocates and innovators of the future.”
— Dr. Kim Daly, DNP, APRN, FNP-C
Regional medical director, vaccines
Becky Donahue
“Merck recognizes the value of our nursing experience and brings our collaborative voice into business decisions that will have a positive impact on the patients and providers we serve.”
— Becky Donahue, MSN, R.N.
Associate director, pharmacovigilance operations and global process enablement
Ron Shank
“I’ve been at Merck for 25 years, but I keep my nursing license current. It allows me to volunteer for medical mission trips and at the local free clinic. Fortunately, the things I love about nursing are part of my job here — like helping improve patients’ lives.”
Forward-looking statement of Merck & Co., Inc., Rahway, N.J., USA
This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). No Duty to Update
The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.
By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.